200 related articles for article (PubMed ID: 18468839)
1. Nebulized furosemide for the management of dyspnea: does the evidence support its use?
Newton PJ; Davidson PM; Macdonald P; Ollerton R; Krum H
J Pain Symptom Manage; 2008 Oct; 36(4):424-41. PubMed ID: 18468839
[TBL] [Abstract][Full Text] [Related]
2. Advances in the pharmacological management of breathlessness.
Currow DC; Ward AM; Abernethy AP
Curr Opin Support Palliat Care; 2009 Jun; 3(2):103-6. PubMed ID: 19333124
[TBL] [Abstract][Full Text] [Related]
3. Nebulized morphine for relief of dyspnea due to chronic lung disease.
Brown SJ; Eichner SF; Jones JR
Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
[TBL] [Abstract][Full Text] [Related]
4. Nebulized medications for the treatment of dyspnea: a literature review.
Boyden JY; Connor SR; Otolorin L; Nathan SD; Fine PG; Davis MS; Muir JC
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):1-19. PubMed ID: 24914770
[TBL] [Abstract][Full Text] [Related]
5. Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients.
Shimoyama N; Shimoyama M
J Pain Symptom Manage; 2002 Jan; 23(1):73-6. PubMed ID: 11779672
[TBL] [Abstract][Full Text] [Related]
6. The role of inhaled opioids and furosemide for the treatment of dyspnea.
Kallet RH
Respir Care; 2007 Jul; 52(7):900-10. PubMed ID: 17594733
[TBL] [Abstract][Full Text] [Related]
7. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline.
Charles MA; Reymond L; Israel F
J Pain Symptom Manage; 2008 Jul; 36(1):29-38. PubMed ID: 18358689
[TBL] [Abstract][Full Text] [Related]
8. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
[TBL] [Abstract][Full Text] [Related]
9. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea.
Kohara H; Ueoka H; Aoe K; Maeda T; Takeyama H; Saito R; Shima Y; Uchitomi Y
J Pain Symptom Manage; 2003 Oct; 26(4):962-7. PubMed ID: 14575057
[TBL] [Abstract][Full Text] [Related]
10. Effect of inhaled furosemide on air hunger induced in healthy humans.
Moosavi SH; Binks AP; Lansing RW; Topulos GP; Banzett RB; Schwartzstein RM
Respir Physiol Neurobiol; 2007 Apr; 156(1):1-8. PubMed ID: 16935035
[TBL] [Abstract][Full Text] [Related]
11. The adjunctive effect of nebulized furosemide in COPD exacerbation: a randomized controlled clinical trial.
Sheikh Motahar Vahedi H; Mahshidfar B; Rabiee H; Saadat S; Shokoohi H; Chardoli M; Rahimi-Movaghar V
Respir Care; 2013 Nov; 58(11):1873-7. PubMed ID: 23650431
[TBL] [Abstract][Full Text] [Related]
12. Aerosol furosemide for dyspnea: Controlled delivery does not improve effectiveness.
Morélot-Panzini C; O'Donnell CR; Lansing RW; Schwartzstein RM; Banzett RB
Respir Physiol Neurobiol; 2018 Jan; 247():146-155. PubMed ID: 29031573
[TBL] [Abstract][Full Text] [Related]
13. Aerosol furosemide for dyspnea: High-dose controlled delivery does not improve effectiveness.
Banzett RB; Schwartzstein RM; Lansing RW; O'Donnell CR
Respir Physiol Neurobiol; 2018 Jan; 247():24-30. PubMed ID: 28843675
[TBL] [Abstract][Full Text] [Related]
14. Nebulized fentanyl provides subjective improvements for patients with dyspnea.
Schultheis CP
Oncol Nurs Forum; 2005 Jan; 32(1):15; author reply 15. PubMed ID: 15682527
[No Abstract] [Full Text] [Related]
15. Controlled Delivery of 80 mg Aerosol Furosemide Does Not Achieve Consistent Dyspnea Relief in Patients.
Hallowell RW; Schwartzstein R; O'Donnell CR; Sheridan A; Banzett RB
Lung; 2020 Feb; 198(1):113-120. PubMed ID: 31728632
[TBL] [Abstract][Full Text] [Related]
16. Can we really say that nebulized morphine works?
Lasheen W; Panneerselvam A; Davis MP
J Pain Symptom Manage; 2006 Aug; 32(2):101-2; author reply 102-3. PubMed ID: 16877173
[No Abstract] [Full Text] [Related]
17. Inhaled furosemide in hospitalized infants with viral bronchiolitis: a randomized, double-blind, placebo-controlled pilot study.
Bar A; Srugo I; Amirav I; Tzverling C; Naftali G; Kugelman A
Pediatr Pulmonol; 2008 Mar; 43(3):261-7. PubMed ID: 18214942
[TBL] [Abstract][Full Text] [Related]
18. Re: nebulized furosemide for dyspnea in terminal cancer patients.
Stone P; Rix ; Kurowska A; Tookman
J Pain Symptom Manage; 2002 Sep; 24(3):274-5; author reply 275-6. PubMed ID: 12458098
[No Abstract] [Full Text] [Related]
19. Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer.
Wilcock A; Walton A; Manderson C; Feathers L; El Khoury B; Lewis M; Chauhan A; Howard P; Bell S; Frisby J; Tattersfield A
Thorax; 2008 Oct; 63(10):872-5. PubMed ID: 18408049
[TBL] [Abstract][Full Text] [Related]
20. Inhaled furosemide for relief of air hunger versus sense of breathing effort: a randomized controlled trial.
Grogono JC; Butler C; Izadi H; Moosavi SH
Respir Res; 2018 Sep; 19(1):181. PubMed ID: 30236110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
